摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert‑butyl (S)‑2‑(p‑tolylcarbamoyl)pyrrolidine‑1‑carboxylate | 52815-83-5

中文名称
——
中文别名
——
英文名称
tert‑butyl (S)‑2‑(p‑tolylcarbamoyl)pyrrolidine‑1‑carboxylate
英文别名
tert-Butyloxycarbonyl-L-prolyl-p-methylanilin;t-Butyl (s)-2-(p-tolylcarbamoyl)pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[(4-methylphenyl)carbamoyl]pyrrolidine-1-carboxylate
tert‑butyl (S)‑2‑(p‑tolylcarbamoyl)pyrrolidine‑1‑carboxylate化学式
CAS
52815-83-5
化学式
C17H24N2O3
mdl
——
分子量
304.389
InChiKey
RKYIEPATGAUQPC-AWEZNQCLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    58.6
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    ( S )-1-甲酰基吡咯烷-2-羧酸衍生物的合成和催化活性对酮和酮亚胺的对映选择性还原
    摘要:
    一系列 (S)-1-甲酰基吡咯烷-2-羧酸衍生物 (6a-t) 已被合成并作为手性有机催化剂用于酮 2 和酮亚胺 3 的不对称还原。这些有机活化剂提供了良好到中等的对映选择性酮和酮亚胺的不对称还原。其中,有机活化剂6h显示出最佳的效率,在酮的还原中提供了84%的收率和41%的ee,在酮亚胺的还原中提供了75%的收率和52%的ee。
    DOI:
    10.3184/030823408x318433
  • 作为产物:
    描述:
    BOC-L-脯氨酸乙烷,三氯氟- 在 Candida antarctica lipase immobilized on acrylic resin 作用下, 以 正庚烷 为溶剂, 反应 72.0h, 以72%的产率得到tert‑butyl (S)‑2‑(p‑tolylcarbamoyl)pyrrolidine‑1‑carboxylate
    参考文献:
    名称:
    CAL-B 介导的苯氧基和芳基丙酸直接酰胺化有效合成一组有价值的酰胺
    摘要:
    报道了在 CAL-B 的辅助下,作为可生物降解的催化剂,一组未活化的羧酸与苯胺的高效、简单和可持续的酰胺化。酶酰胺化反应是在一组非甾体抗炎药 (NSAID)、苯氧基丙酸和受保护的脯氨酸上进行的,方法是在 80°C 下反应 72 小时后,在庚烷中直接缩合一当量羧酸和两当量苯胺衍生物. 回收得到的羧酰胺,分离的化学产率介于中等和极好之间。首次报道了其中的14个,得到了X射线晶体:N-(4-碘苯基)-2-(4-异丁基苯基)丙酰胺1d。
    DOI:
    10.1007/s11696-021-01636-5
点击查看最新优质反应信息

文献信息

  • Simple, inexpensive, and facile l-prolinamide used as a recyclable organocatalyst for highly efficient large-scale asymmetric direct aldol reactions
    作者:Jiangwei Xu、Xiangkai Fu、Chuanlong Wu、Xiaoyan Hu
    DOI:10.1016/j.tetasy.2011.05.008
    日期:2011.4
    In order to discover a simple, inexpensive, and efficient route to obtain highly enantiomerically enriched anti-aldol products for applications in industry, a series of prolinamides 1-5 with different carbocyclic rings have been synthesized from achiral cycloalkylamine, and prolinamides 6-9 have been synthesized from aniline with different substituents. The organocatalysts obtained catalyzed the asymmetric aldol reaction and showed that no matter carbocyclic rings or aromatic rings were found to play a significant role in the formation of the aldol products. Moreover, the prolinamide 6 exhibited efficient catalytic activity in the asymmetric aldol reaction only with 5 mol % catalyst loading and 4 equiv of ketone, and afforded aldol products in high diastereoselectivity (up to anti/syn 99:1) and enantioselectivity (99%) and significantly enhanced the reaction yield (99%). These results were much better than L-proline-3-nitroanilide which had the strongest electron-withdrawing group on the aromatic ring. Furthermore, catalyst 6 can be easily recovered and reused, without a significant decrease of enantioselectivity after five cycles. This inexpensive, simple, and recyclable catalyst can be efficiently used in large-scale reactions with the enantioselectivities being maintained at the same level, which offers a great possibility for application in industry. (C) 2011 Elsevier Ltd. All rights reserved.
  • Synthesis of Analogues of <scp>BCTC</scp> Incorporating a Pyrrolidinyl Linker and Biological Evaluation as Transient Receptor Potential Vanilloid 1 Antagonists
    作者:Lin Yan、Jingjie Wang、Miaobo Pan、Qianqian Qiu、Wenlong Huang、Hai Qian
    DOI:10.1111/cbdd.12661
    日期:2016.2
    A series of novel pyrrolidinyl linker TRPV1 antagonists were prepared in an effort to lower the hyperthermic side‐effects of first‐generation antagonist BCTC. These compounds were investigated for antagonism of hTRPV1 activation by capsaicin and acid in vitro. Preliminary results suggested the compounds 10a, 10b, 10c and 10j had favorable TRPV1 antagonism activity. In further studies in vivo, 10b, comparable to BCTC, showed potent analgesic activity in capsaicin‐induced and heat‐induced pain models. In addition, 10b indicated a reduced risk of body temperature elevation. All of these demonstrated that 10b can be considered as a safe candidate for the further development of analgesic drugs.
  • CAL-B-mediated efficient synthesis of a set of valuable amides by direct amidation of phenoxy- and aryl-propionic acids
    作者:Nourelhouda Benamara、Mounia Merabet-Khelassi、Louisa Aribi-Zouioueche、Olivier Riant
    DOI:10.1007/s11696-021-01636-5
    日期:2021.8
    efficient, easy and sustainable amidation of a set of non-activated carboxylic acids with anilines, assisted by CAL-B, as biodegradable catalyst, is reported. The enzymatic amidation reactions are performed on set of nonsteroidal anti-inflammatory drugs (NSAIDs), phenoxypropionic acid and protected-prolines by direct condensation of one equivalent of carboxylic acids and two equivalents of anilines
    报道了在 CAL-B 的辅助下,作为可生物降解的催化剂,一组未活化的羧酸与苯胺的高效、简单和可持续的酰胺化。酶酰胺化反应是在一组非甾体抗炎药 (NSAID)、苯氧基丙酸和受保护的脯氨酸上进行的,方法是在 80°C 下反应 72 小时后,在庚烷中直接缩合一当量羧酸和两当量苯胺衍生物. 回收得到的羧酰胺,分离的化学产率介于中等和极好之间。首次报道了其中的14个,得到了X射线晶体:N-(4-碘苯基)-2-(4-异丁基苯基)丙酰胺1d。
  • Synthesis and Catalytic Activities of (<i>S</i>)-1-formylpyrrolidine-2-carboxylic Acid Derivatives for the Enantioselective Reductions of Both a Ketone and a Ketimine
    作者:Zhenfei Chen、Anjiang Zhang、Lixue Zhang、Jing Zhang、Xinxiang Lei
    DOI:10.3184/030823408x318433
    日期:2008.5
    as chiral organocatalysts in the asymmetric reduction of both ketone 2 and ketimine 3. These organic activators afforded good to moderate enantioselectivities in the asymmetric reductions of both the ketone and the ketimine. Among them, organic activator 6h displayed the best efficiency, affording a 84% yield and 41% ee in the reduction of the ketone and 75% yield and 52% ee in the reduction of the ketimine
    一系列 (S)-1-甲酰基吡咯烷-2-羧酸衍生物 (6a-t) 已被合成并作为手性有机催化剂用于酮 2 和酮亚胺 3 的不对称还原。这些有机活化剂提供了良好到中等的对映选择性酮和酮亚胺的不对称还原。其中,有机活化剂6h显示出最佳的效率,在酮的还原中提供了84%的收率和41%的ee,在酮亚胺的还原中提供了75%的收率和52%的ee。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物